Decoding the role of Netrin-1 receptor shedding during cancer cell survival
Decoding the role of Netrin-1 receptor shedding during cancer cell survival
批准号:
409684139
负责人:
Dr. Denise Nikodemus, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2020-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cancer is a leading cause of death worldwide and its incidence is rising. Therefore, in order to invent effective therapeutics, it is of global and urgent interest to understand the molecular mechanisms of cancer development and progression. Deregulation of programmed cell death, known as apoptosis, is a key strategy of cancer cells to ensure their own survival. However, how cancer cells escape cell death is poorly understood. Tumour surrounding stromal cells significantly influence tumour progression. Here, I identified the secreted extracellular matrix protein Netrin-1 to be highly up-regulated in stromal cells in response to invasive cancer cell stimuli. Netrin-1, a neuronal guidance molecule, has emerged as an essential cell survival factor in cancer, acting through its dependence receptors. In the absence of Netrin-1, these receptors induce apoptosis. Thus, targeting Netrin-1 receptor signalling represents a promising therapeutic approach. My preliminary data decode a novel mechanism through which cancer cells regulate Netrin-1 receptor induced cell fate. Here, ADAM metalloproteases ensure the equilibrium between cell survival and cell death by shedding netrin-1 receptors. Based on my data, I hypothesize that elimination of Netrin-1 together with blockade of Netrin-1 receptor shedding induces cancer cell apoptosis. To translate my findings into the clinic, I will develop blocking peptides and/or antibodies to inhibit tumour progression by causing cancer cell death. Thus, successful completion of this project will not only yield in-depth insight into a novel molecular mechanism of Netrin-1 receptor shedding through metalloproteases during cancer cell survival, but also identify a promising strategy for cancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
-
批准号:82371070
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵培泉
-
依托单位: